June 28, 2017

Platform Technology

MangoGen has a patent technology that describes the encapsulation of genetically modified baculoviruses coated on to medical device.

MangoGen’s focus is on developing gene-delivering coronary stents, film dressings and sutures, but any medical device could be coated to deliver a gene(s) to perform a particular task.

MangoGen has entered into a collaboration with Orgenesis to develop cell therapies for diabetes that utilize baculoviral gene-delivery.